The US Food and Drug Administration has authorised at-home use of nasal spray vaccine FluMist, opening the door for needle-shy people to have easy to live-saving immunisation. The US Food and Drug Administration has authorised at-home use of nasal spray vaccine FluMist, opening the door for needle-shy people to have easy to live-saving immunisation. World / North America Sydney Morning Herald – Latest News